Anti-PD-1 combined with an agonistic OX40 antibody in OC murine models increased CD8+ T-cell function and markedly reduced tumour growth, such that 60% of animals were tumour-free at 90 days [299]. The gene discussed is CD8A; the disease is neoplasm.